Genetic testing for blood cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This study offers genetic testing to people newly diagnosed with a blood cancer. It looks for inherited gene changes that might affect your cancer or your family's health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have just been diagnosed with a blood cancer (like leukemia or lymphoma).
- Your diagnostic bone marrow test will be done at the Georgia Cancer Center.
- You can give consent in English and are willing to have a small skin sample taken for comparison.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
This study looks for inherited gene changes in people with myeloproliferative neoplasms (MPNs) who have a family history of similar blood disorders. If you qualify, it may help explain why some families have higher risk and could guide future screening.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
Hear when a new Hematologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.